Fabiani, Emiliano
 Distribuzione geografica
Continente #
NA - Nord America 2.079
EU - Europa 2.002
AS - Asia 752
SA - Sud America 121
AF - Africa 19
OC - Oceania 6
Continente sconosciuto - Info sul continente non disponibili 4
Totale 4.983
Nazione #
US - Stati Uniti d'America 2.065
DE - Germania 843
SE - Svezia 389
CN - Cina 387
SG - Singapore 188
UA - Ucraina 162
IT - Italia 128
PL - Polonia 107
FR - Francia 106
BR - Brasile 103
IE - Irlanda 68
GB - Regno Unito 55
IN - India 48
FI - Finlandia 41
ID - Indonesia 41
RU - Federazione Russa 32
JP - Giappone 18
TR - Turchia 12
KR - Corea 11
NL - Olanda 11
BE - Belgio 10
VN - Vietnam 10
AT - Austria 9
CA - Canada 9
CI - Costa d'Avorio 9
CZ - Repubblica Ceca 7
AU - Australia 6
CO - Colombia 6
GR - Grecia 6
IR - Iran 6
AR - Argentina 5
AE - Emirati Arabi Uniti 4
BG - Bulgaria 4
CL - Cile 4
ES - Italia 4
LT - Lituania 4
MX - Messico 4
ZA - Sudafrica 4
BD - Bangladesh 3
CH - Svizzera 3
HK - Hong Kong 3
NO - Norvegia 3
PK - Pakistan 3
TH - Thailandia 3
EG - Egitto 2
HR - Croazia 2
IL - Israele 2
IQ - Iraq 2
JO - Giordania 2
LA - Repubblica Popolare Democratica del Laos 2
XK - ???statistics.table.value.countryCode.XK??? 2
A1 - Anonimo 1
BO - Bolivia 1
BW - Botswana 1
DO - Repubblica Dominicana 1
EC - Ecuador 1
EU - Europa 1
HU - Ungheria 1
IS - Islanda 1
KE - Kenya 1
KG - Kirghizistan 1
KZ - Kazakistan 1
LK - Sri Lanka 1
LV - Lettonia 1
MA - Marocco 1
ME - Montenegro 1
MK - Macedonia 1
PH - Filippine 1
PS - Palestinian Territory 1
PT - Portogallo 1
PY - Paraguay 1
RO - Romania 1
SA - Arabia Saudita 1
SK - Slovacchia (Repubblica Slovacca) 1
TN - Tunisia 1
UZ - Uzbekistan 1
Totale 4.983
Città #
Chandler 352
Singapore 127
Jacksonville 118
Ashburn 107
Warsaw 106
Dearborn 92
Nanjing 85
Houston 82
San Mateo 78
Ann Arbor 72
Chicago 70
Dublin 63
New York 58
Wilmington 55
Woodbridge 55
Los Angeles 53
Fairfield 43
Nürnberg 41
Jakarta 39
Bremen 38
Milan 35
Beijing 31
Nanchang 31
Seattle 30
Buffalo 27
Lawrence 27
Redwood City 27
Moscow 26
Salt Lake City 26
Munich 25
Boston 23
Marseille 20
Cattolica 18
Shanghai 18
Chatsworth 16
Kunming 16
Hangzhou 15
Hefei 15
Guangzhou 14
Leawood 14
Auburn Hills 13
Changsha 13
São Paulo 13
Tampa 13
Zhengzhou 13
Shenyang 12
Cambridge 11
Elk Grove Village 11
Princeton 11
Pune 11
Mountain View 10
Tianjin 10
Abidjan 9
Brussels 9
Frankfurt am Main 9
Jiaxing 9
London 9
Rome 9
University Park 9
Augusta 8
Fremont 8
Hebei 8
Helsinki 8
Izmir 8
Jinan 8
Lanzhou 7
Miami 7
Tokyo 7
Washington 7
Belo Horizonte 6
Boardman 6
Edinburgh 6
Enterprise 6
Lancaster 6
Seoul 6
Barletta 5
Costa Mesa 5
Hanoi 5
Las Vegas 5
Monmouth Junction 5
Norwalk 5
Nuremberg 5
Paris 5
Phoenix 5
Portsmouth 5
San Jose 5
Simi Valley 5
Sterling 5
Athens 4
Atlanta 4
Dallas 4
Medellín 4
Philadelphia 4
Seo-gu 4
The Dalles 4
Andover 3
Brooklyn 3
Cape Town 3
Chengdu 3
Detroit 3
Totale 2.612
Nome #
5-azacytidine in chronic myelomonocytic leukemia: case report and review of literature 372
Fanconi anemia gene variants in therapy-related myeloid neoplasms 274
Mutational analysis of bone marrow mesenchymal stromal cells in myeloid malignancies 217
PTEN/PI3K/AKT PATHWAY DYSREGULATION IN MYELODYSPLASTIC GRANULOCYTES 192
MUTATIONAL ANALYSIS OF BONE MARROW MESENCHIMAL STROMAL CELLS IN MYELOID MALIGNANCIES 177
GSK3β down-regulation in Mesenchymal Stem Cells from patients with Myelodysplastic Syndrome. 166
DEREGULATION OF PI3K/AKT SIGNALING IN BONE MARROW MESENCHIMAL STROMAL CELLS FROM PATIENTS WITH DE NOVO AND THERAPY-RELATED ACUTE MYELOID LEUKEMIA 155
MTHFR polymorphysms in myelodysplastic syndromes and therapy-related myeloid neoplasms 150
Characteristics and outcome of therapy-related myeloid neoplasms: Report from the italian network on secondary leukemias. 146
Why methylation is not a marker predictive of response to hypomethylating agents 143
Mutations of epigenetic regulators and of the spliceosome machinery in therapy-related myeloid neoplasms and in acute leukemias evolved from chronic myeloproliferative diseases 142
Mutations of epigenetic regulators and of the spliceosome machinery in therapy-related myeloid neoplasms and in acute leukemias evolved from chronic myeloproliferative diseases 139
SETBP1 mutations in 106 patients with therapy-related myeloid neoplasms. 139
Increased risk of acute myeloid leukaemia due to polymorphisms in detoxification and DNA repair enzymes. 137
Analysis of genome-wide methylation and gene expression induced by 5-aza-2'-deoxycytidine identifies BCL2L10 as a frequent methylation target in acute myeloid leukemia. 132
Impairment of PI3K/AKT and WNT/β-catenin pathways in bone marrow mesenchymal stem cells isolated from patients with myelodysplastic syndromes 132
Reduced BRCA1 expression due to promoter hypermethylation in therapy-related acute myeloid leukaemia 131
Promoter methylation of DAPK1, E-cadherin and thrombospondin-1 in de novo and therapy-related myeloid neoplasms 125
Gene expression profiling of myelodysplastic CD34+ hematopoietic stem cells treated in vitro with decitabine 121
Epigenetic changes in therapy-related MDS/AML 117
Polymorphisms of detoxification and DNA repair enzymes in myelodyplastic syndromes 116
Similarities and differences between therapy-related and elderly acute myeloid leukemia 115
Promoter methylation of DAPK1, E-cadherin and thrombospondin-1 in de novo and therapy-related myeloid neoplasms 115
Role of BCL2L10 methylation and TET2 mutations in higher risk myelodysplastic syndromes treated with 5-azacytidine 108
PU.1 and CEBPA expression in acute myeloid leukemia. 108
The BCL2L10 Leu21Arg variant and risk of therapy-related myeloid neoplasms and de novo myelodysplastic syndromes 101
Prognostic role of glutathione S-transferase polymorphisms in acute myeloid leukemia. 99
Clonal evolution in therapy-related neoplasms 97
Valproic acid at therapeutic plasma levels may increase 5-azacytidine efficacy in higher risk myelodysplastic syndromes. 96
Endothelial progenitor cell dysfunction in myelodysplastic syndromes: possible contribution of a defective vascular niche to myelodysplasia 95
Children with special health care needs attending emergency department in Italy: analysis of 3479 cases 93
Transcription factors implicated in late megakaryopoiesis as markers of outcome after azacitidine and allogeneic stem cell transplantation in myelodysplastic syndrome 88
Development of a High-Resolution Melting Curve Analysis Screening Test for SRSF2 Splicing Factor Gene Mutations in Myelodysplastic Syndromes 84
Impairment of PI3K/AKT and WNT/β-catenin pathways in bone marrow mesenchymal stem cells isolated from patients with myelodysplastic syndromes 84
Therapy-related myeloid neoplasms: Clinical perspectives 75
Myelodysplastic disorders carrying both isolated del(5q) and JAK2(V617F) mutation: concise review, with focus on lenalidomide therapy 72
In vitro Effect of Eltrombopag Alone and in Combination With Azacitidine on Megakaryopoiesis in Patients With Myelodysplastic Syndrome 67
Time- and residue-specific differences in histone acetylation induced by VPA and SAHA in AML1/ETO-positive leukemia cells 53
In vitro effect of eltrombopag alone and in combination with azacitidine on megakaryopoiesis in patients with myelodysplastic syndrome 26
Impairment of FOXM1 expression in mesenchymal cells from patients with myeloid neoplasms, de novo and therapy-related, may compromise their ability to support hematopoiesis 15
Totale 5.014
Categoria #
all - tutte 17.158
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 17.158


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/202082 0 0 0 0 0 0 0 0 0 0 40 42
2020/2021546 18 37 10 38 57 59 93 7 47 45 114 21
2021/2022392 45 39 5 11 31 19 5 76 17 40 49 55
2022/2023954 140 144 77 181 56 99 36 93 76 3 36 13
2023/2024378 21 95 10 15 18 95 5 15 5 7 45 47
2024/2025843 19 22 70 22 80 15 47 36 110 58 364 0
Totale 5.014